ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AG9. A total of 11 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $13,576,000 | +75.7% | 6,112,000 | +19.6% | 3.94% | +172.8% |
Q2 2016 | $7,726,000 | -0.5% | 5,112,000 | +64.3% | 1.44% | -23.4% |
Q1 2016 | $7,761,000 | -1.7% | 3,112,000 | +47.3% | 1.89% | -33.3% |
Q4 2015 | $7,892,000 | +105.5% | 2,112,000 | +111.2% | 2.83% | +160.8% |
Q1 2015 | $3,841,000 | -56.8% | 1,000,000 | -58.2% | 1.08% | -52.7% |
Q4 2014 | $8,892,000 | – | 2,393,000 | – | 2.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WOLVERINE ASSET MANAGEMENT LLC | 35,441,000 | $87,701,000 | 2.49% |
EQUITEC SPECIALISTS, LLC | 3,112,000 | $7,761,000 | 1.89% |
WHITEBOX ADVISORS LLC | 11,246,000 | $28,045,000 | 0.82% |
FMR LLC | 6,000,000 | $14,963,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 300,000 | $730,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 5,000 | $12,000 | 0.00% |